Fig. (3).
% release of MLT vs. time from formulations (a) CA1, CA2, PV1, HP1, HP2 and (b) CAPV1-CAPV5 at pH 1.2, with hard gelatin capsules, (c) CA1, CA2, PV1, HP1, HP2 and (d) CAPV1-CAPV5 at pH 6.8, with hard gelatin capsules, (e) CA1, CA2, PV1, HP1, HP2 and (f) CAPV1-CAPV5 at pH 6.8, with DRcapsTM capsules.